D-2570 Tablet

DRUG2 trials

Sponsors

InventisBio Co., Ltd

Conditions

Plaque PsoriasisPsoriasis

Phase 2

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

RecruitingNCT07489885

InventisBio Co., LtdPsoriasis

Start: 2026-06-03End: 2027-12-01Target: 75Updated: 2026-07-09

Phase 3

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

RecruitingNCT07326813

InventisBio Co., LtdPlaque Psoriasis

Start: 2026-01-12End: 2027-12-03Target: 477Updated: 2026-04-29